Testing effectiveness (Phase 2)Study completedNCT03695510
What this trial is testing
Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study)
Who this might be right for
Head and Neck Neoplasms
National Taiwan University Hospital 29